NCT02289235View on ClinicalTrials.gov

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

February 1, 2020

Conditions
Fatty LiverDiabetes Mellitus, Type 2
Interventions
DRUG

Ginger

Ginger powder capsule 1000 mg twice daily for 3 months

DRUG

Placebo

Placebo powder 2 capsules twice daily for 3 months

Trial Locations (1)

Unknown

Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT02289235 - Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM | Biotech Hunter | Biotech Hunter